Q3 2024 Sabra Health Care REIT Inc Earnings Call

In This Article:

Participants

Lukas Hartwich; Senior Vice President, Finance; Sabra Health Care REIT Inc

Richard Matros; Chairman of the Board, President, Chief Executive Officer; Sabra Health Care REIT Inc

Talya Nevo-Hacohen; Executive Vice President, Chief Investment Officer, Treasurer; Sabra Health Care REIT Inc

Michael Costa; Chief Financial Officer, Executive Vice President, Company Secretary; Sabra Health Care REIT Inc

Elmer Chang; Analyst; Scotiabank

William John Kilichowski; Analyst; Wells Fargo

Austin Wurschmidt; Analyst; KeyBanc Capital Markets

Juan Sanabria; Analyst; BMO Capital Markets

Michael Griffin; Analyst; Citi

Richard Anderson; Analyst; Wedbush Securities Inc

Alec Feygin; Analyst; Robert W. Baird & Co Inc

Michael Stroyeck; Analyst; Green Street Advisors

Omotayo Okusanya; Analyst; Deutsche Bank

Presentation

Operator

Good day, everyone. My name is Adam, and I'll be you conference operator today. At this time, I would like to welcome everyone to the Sabra third-quarter 2024 earnings call. (Operator Instructions)
I'd like to now turn the call over to Lukas Hartwich, SVP of Finance. Please go ahead, Mr. Hartwich.

Lukas Hartwich

Thank you and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our earnings guidance for 2024, and our expectations regarding our tenants and operators and our expectations regarding our acquisition, disposition and investment plans.
These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2023, as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday. We undertake no obligation to update our forward-looking statements to reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid.
In addition, references will be made during this call to non-GAAP financial results. Investors are encouraged to review these non-GAAP financial measures as well as the explanation and reconciliation of these measures to the comparable GAAP results included on the Financials page of the Investors section of our website at sabrahealth.com. Our Form 10-Q, earnings release, and supplement can also be accessed in the Investors section of our website.
And with that, let me turn the call over to Rick Matros, CEO, President and Chair of Sabra Health Care REIT.

Waiting for permission
Allow microphone access to enable voice search

Try again.